Funding for this research was provided by:
National Cancer Institute (CA204767)
Received: 9 August 2020
Accepted: 24 March 2021
First Online: 7 April 2021
: This study was approved by the Institutional Review Board at the University of Kansas Medical Center. All participants gave verbal informed consent to participate, as approved by the Institutional Review Board. Written consent was waived as the study posed only minimal harm to respondents. Not other administrative approvals were required.
: Not applicable.
: The authors declare that they have no competing interests.